- Home
- PBA vs DXCM Comparison
PBA vs DXCM Comparison
Compare PBA & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$70.24
Company Overview
Basic Information| Metric | PBA | DXCM |
|---|---|---|
| Founded | 1997 | 1999 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.6B | 25.9B |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | PBA | DXCM |
|---|---|---|
| Price | $36.49 | $70.24 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 21 |
| Target Price | N/A | ★ $86.86 |
| AVG Volume (30 Days) | 1.3M | ★ 4.5M |
| Earning Date | 02-26-2026 | 02-12-2026 |
| Dividend Yield | ★ 5.51% | N/A |
| EPS Growth | N/A | ★ 7.75 |
| EPS | ★ 2.01 | 1.80 |
| Revenue | ★ $5,750,633,574.00 | $4,515,900,000.00 |
| Revenue This Year | $7.53 | $17.38 |
| Revenue Next Year | $3.87 | $12.76 |
| P/E Ratio | ★ $18.33 | $38.90 |
| Revenue Growth | 13.22 | ★ 14.21 |
| 52 Week Low | $34.13 | $54.11 |
| 52 Week High | $42.40 | $93.25 |
Technical Indicators
Market Signals| Indicator | PBA | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 36.52 | 68.09 |
| Support Level | $36.72 | $65.19 |
| Resistance Level | $38.71 | $68.18 |
| Average True Range (ATR) | 0.72 | 1.51 |
| MACD | -0.12 | 0.20 |
| Stochastic Oscillator | 0.42 | 87.78 |
Price Performance
Historical Comparison PBA
DXCM
About PBA Pembina Pipeline Corp. (Canada)
Pembina Pipeline is a midstream company serving the Canadian and North American (primarily Bakken) markets with an integrated product portfolio. Its operations include transmission pipelines, oil and gas gathering, fractionation, storage, and natural gas liquid exports.
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.